The Nucleic Acid Labelling Market Is Predicted To Reach USD 2090.87 Million With A CAGR Of 8.65% According To Market Data Forecast Report.

The Nucleic Acid Labelling Market Is Predicted To Reach USD 2090.87 Million With A CAGR Of 8.65% According To Market Data Forecast Report.

ID: 6824 | October 2018 | Region: Global

The Nucleic Acid Labelling Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Nucleic Acid Labelling Market is estimated to be USD 1381.81 million in 2016 and predicted to rise to USD 2090.27 million by 2021 with a CAGR of 8.65%. The market is segmented by Product (Reagents & Kits, Services), by Labelling Technique (PCR, Nick Translation, Random Primer, In-Vitro Transcription, Reverse Transcription), by Application (DNA Sequencing, PCR, FISH, Microarrays, Blotting, In-Situ Hybridization), by End Users (Diagnostic Centres, Research Centres, Hospitals). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.

Primary factors driving the market forward are increasing demand for personalized healthcare, increasing funding for R&D in genomics and disease diagnosis, increasing expenditure for health care. On the other hand, factors like expensive processing techniques and lack of skilled professionals are likely to restrict the growth of market.

DNA sequencing occupies major share in terms of Applications due to its uses in identification of genetic disorders, tumour genetic variations. Reagents and Kits occupy major share among products segment due to their numerous uses in Diagnostic and Research Centres. Based on End User Research Centres occupy the major share owing to increasing government funding to increase research activity and drug discovery.

North America is leading the market while Europe is at second place. Increasing personalized medicines, identifying the genetic modifications and therapeutic areas have enabled North America to dominate the market. Asia Pacific is expected to grow the fastest due to government initiatives to develop healthcare infrastructure and making the products cost efficient and increased R&D expenditure.

Some of the key players dominating this market include Thermo Fisher Scientific, New England Biolabs, PerkinElmer, F. Hoffmann La-Roche AG, General Electric Company, Merck KGaA, Enzo Biochem, Promega Corporation, Vector Laboratories, and Agilent Technologies.

Browse through the full report at and checkout our recent reports in the Healthcare at For more insights and up-to-date industry news don’t forget subscribing to our newsletters.

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)

Subscribe To Our News Letter

Or follow us on social platform

© 2019 Market Data Forecast
All Rights Reserved.